NasdaqGS - Nasdaq Real Time Price USD

Exelixis, Inc. (EXEL)

Compare
35.61 +0.78 (+2.24%)
At close: 4:00 PM EST
35.74 +0.13 (+0.37%)
After hours: 4:57 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 539.54M
Earnings 117.97M
Q4'23
Q1'24
Q2'24
Q3'24
0
200M
400M
600M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

18.90 Low
31.83 Average
35.61 Current
38.00

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1451315
Avg. Estimate 0.490.391.951.96
Low Estimate 0.250.281.731.37
High Estimate 0.750.482.222.45
Year Ago EPS 0.330.170.91.95

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1571821
Avg. Estimate 561.68M496.33M2.16B2.18B
Low Estimate 548M470.1M2.15B1.96B
High Estimate 579M515.73M2.18B2.4B
Year Ago Sales 479.65M425.23M1.83B2.16B
Sales Growth (year/est) 17.10%16.72%18.14%1.03%

Earnings History

CURRENCY IN USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.310.290.370.42
EPS Actual 0.330.170.840.47
Difference 0.02-0.120.470.05
Surprise % 6.80%-40.64%129.85%12.02%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.490.391.951.96
7 Days Ago 0.40.361.791.77
30 Days Ago 0.40.391.791.74
60 Days Ago 0.40.391.81.76
90 Days Ago 0.430.341.371.69

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 831110
Up Last 30 Days 821110
Down Last 7 Days 2--12
Down Last 30 Days 2--12

Growth Estimates

CURRENCY IN USD EXELIndustrySectorS&P 500
Current Qtr. 47.51%----5.00%
Next Qtr. 131.76%----12.00%
Current Year 116.94%----2.10%
Next Year 0.52%----12.20%

Upgrades & Downgrades

Maintains Guggenheim: Buy to Buy 10/30/2024
Maintains Stephens & Co.: Equal-Weight to Equal-Weight 10/30/2024
Maintains Piper Sandler: Overweight to Overweight 10/30/2024
Reiterates RBC Capital: Outperform to Outperform 10/30/2024
Maintains Truist Securities: Buy to Buy 10/30/2024
Maintains Wells Fargo: Overweight to Overweight 10/30/2024

Related Tickers